Hyun Kyoung Lee, Ju Yeon Lee, Gun Wook Park, Young Hee Ahn, Jin Young Kim, Jong Shin Yoo
언어
영어(ENG)
URL
https://www.earticle.net/Article/A294826
※ 원문제공기관과의 협약기간이 종료되어 열람이 제한될 수 있습니다.
원문정보
초록
영어
Glycosylation is one of the most important post-translational modifications of protein, which plays a key role on the stability and immunogenicity of therapeutic monoclonal antibodies (mAbs). Alteration in N-glycoforms may significantly modify the biological activity of mAbs. The unexpected and heterogeneous N-glycoforms are often reported, because it is affected by the culture medium, the efficiency of protein expression, and the physiological status of the host cells. Thus, accurate identification and quantification of their N-glycoform are necessary in order to control the production processes. In this study, IgG (Human serum), two NIST (National institute of standards and technology), and three unknown therapeutic mAb samples were analyzed by LC-MS/MS and GPA (GlycoProteome Analyzer) system1. As a result, the complex types of N-glycoforms were identified in IgG and unknown sample A, whereas different high-mannose and hybrid types of N-glycoforms were identified in two NIST samples and unknown sample B and C. The quantitative patterns of N-glycoform were similar between IgG and unknown sample A. The hybrid type and high-mannose type of N-glycoform were quantitatively increased in two NIST samples and unknown sample B and C, respectively. This analytical method will be useful for verification of safety and efficacy in various biopharmaceutical products such as therapeutic monoclonal antibodies.
저자
Hyun Kyoung Lee [ Biomedical Omics Group, Korea Basic Science Institute, Cheongju, Republic of Korea, Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea ]
Ju Yeon Lee [ Biomedical Omics Group, Korea Basic Science Institute, Cheongju, Republic of Korea ]
Gun Wook Park [ Biomedical Omics Group, Korea Basic Science Institute, Cheongju, Republic of Korea ]
Young Hee Ahn [ Department of Biomedical Science, Cheongju University, Cheongju, Republic of Korea ]
Jin Young Kim [ Biomedical Omics Group, Korea Basic Science Institute, Cheongju, Republic of Korea ]
Jong Shin Yoo [ Biomedical Omics Group, Korea Basic Science Institute, Cheongju, Republic of Korea, Graduate School of Analytical Science and Technology, Chungnam National University, Daejeon, Republic of Korea ]
본 학회는 화학, 생화학, 분자생물학, 미생물학, 식품공학, 의학, 약학, 유전공학 및 생물공학, 환경 및 기타 공업 등 전 분야의 탄수화물관련 이론과 기술을 연구 발전시키고 산학협동을 통해 이를 보급하여 국내 관련 산업의 발전 및 국민생활의 과학화에 기여하고자 하며, 이러한 목표와 비젼의 실현을 위해 회원들이 적극적인 참여와 활동을 전개하고자 한다.